Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Tobacco Use Disorder 2Rectal Neoplasms 2Precancerous Conditions 2Colorectal Neoplasms 2Colonic Neoplasms 2Barrett Esophagus 2Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Leukoplakia, Oral 1Leukemia, Hairy Cell 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Adenomatous Polyps 1Adenocarcinoma Of Esophagus 1

Interventions

Carboplatin 41Cisplatin 38Paclitaxel 34Specimen Handling 32Radiotherapy 27Magnetic Resonance Spectroscopy 25Gemcitabine 23Vinorelbine 15Etoposide 15Docetaxel 15Biopsy 13Pemetrexed 10Cyclophosphamide 10pembrolizumab 9Taxes 9Immunoglobulin G 9Disulfides 9Platinum 81,2-diaminocyclohexaneplatinum II citrate 8X-Rays 7Vinblastine 7Erlotinib Hydrochloride 7osimertinib 6durvalumab 6atezolizumab 6Nivolumab 6Irinotecan 6Ifosfamide 6Chemotherapy, Adjuvant 6Celecoxib 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Lung Neoplasms × Aspirin × Clear all
NCT02123849 2018-08-29

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

National Cancer Institute (NCI)

Phase 2 Completed
54 enrolled 15 charts
Thoracic

Lung Neoplasms, Tobacco Use Disorder

Data powered by HemOnc (CC BY 4.0) Colophon âš¡